InvestorsHub Logo
Followers 6
Posts 774
Boards Moderated 0
Alias Born 03/07/2014

Re: diversify post# 48058

Tuesday, 11/29/2016 9:25:02 PM

Tuesday, November 29, 2016 9:25:02 PM

Post# of 140475
Another way to look at it, the new CEO has a chance to be the first CEO of Titan to bring SPORT to market and compete in deals. I think a more difficult sell is to a CEO that needs to come in after the market (not investment market, but customer market) has rejected the product and customers are not buying. The new CEO will be able to craft the first impression to the clinical market of what this robot can do, and that is a great position to be in. The reality is that even after SPORT is FDA approved, most surgeons won't see SPORT or know anything about it until the hospital they work at or surgery center they own is buying a robot, and they are conducting a formal evaluation. 95% of customers will have no idea that Titan was valued at $.29 and had a market cap of $48 million back in late Nov/early Dec 2016.